GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valeo Pharma Inc (OTCPK:VPHIF) » Definitions » Price-to-Free-Cash-Flow

Valeo Pharma (Valeo Pharma) Price-to-Free-Cash-Flow : N/A (As of May. 01, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Valeo Pharma Price-to-Free-Cash-Flow?

As of today (2024-05-01), Valeo Pharma's share price is $0.03432. Valeo Pharma's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jan. 2024 was $-0.07. Hence, Valeo Pharma's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Valeo Pharma's Price-to-Free-Cash-Flow or its related term are showing as below:

VPHIF's Price-to-Free-Cash-Flow is not ranked *
in the Drug Manufacturers industry.
Industry Median: 22.38
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Valeo Pharma's Free Cash Flow per Share for the three months ended in Jan. 2024 was $0.01. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-0.07.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -28.70% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -58.50% per year.

During the past 7 years, Valeo Pharma's highest 3-Year average Free Cash Flow per Share Growth Rate was -28.70% per year. The lowest was -87.90% per year. And the median was -58.85% per year.


Valeo Pharma Price-to-Free-Cash-Flow Historical Data

The historical data trend for Valeo Pharma's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valeo Pharma Price-to-Free-Cash-Flow Chart

Valeo Pharma Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - - - - -

Valeo Pharma Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Valeo Pharma's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Valeo Pharma's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Valeo Pharma's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Valeo Pharma's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Valeo Pharma's Price-to-Free-Cash-Flow falls into.



Valeo Pharma Price-to-Free-Cash-Flow Calculation

Valeo Pharma's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.03432/-0.066
=N/A

Valeo Pharma's Share Price of today is $0.03432.
Valeo Pharma's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.07.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Valeo Pharma  (OTCPK:VPHIF) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Valeo Pharma Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Valeo Pharma's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Valeo Pharma (Valeo Pharma) Business Description

Traded in Other Exchanges
Address
16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9
Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and Niche hospital injectable products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.